ProductsBack/Annexin III antibody

Annexin III antibody

Name: Annexin III antibody
SKU: GTX103330_G10
Availability: BackOrder

GTX103330

ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

ReactivityHuman, Rat

TargetANXA3

Overview

Supplier
GeneTex
Product Name
Annexin III antibody
Delivery Days Customer
9
Application Supplier Note
WB: 1:5000-1:20000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
1 mg/ml
Conjugate
Unconjugated
Gene ID306
Target name
ANXA3
Target description
annexin A3
Target synonyms
ANX3, annexin A3, 35-alpha calcimedin, Annexin III (lipocortin III), PAP-III, annexin III (lipocortin III, 1,2-cyclic-inositol-phosphate phosphodiesterase, placental anticoagulant protein III, calcimedin 35-alpha), annexin-3, calcimedin 35-alpha, inositol 1,2-cyclic phosphate 2-phosphohydrolase, lipocortin III, placental anticoagulant protein III
Host
Rabbit
Isotype
IgG
Protein IDP12429
Protein Name
Annexin A3
Scientific Description
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions in the inhibition of phopholipase A2 and cleavage of inositol 1,2-cyclic phosphate to form inositol 1-phosphate. This protein may also play a role in anti-coagulation. [provided by RefSeq]
Reactivity
Human, Rat
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Chai X, Wu X, Ren J, et al. Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma. Transl Cancer Res. 2022,11(6):1644-1651. doi: 10.21037/tcr-22-1277
Read this paper
Du K, Ren J, Fu Z, et al. ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growth. Transl Cancer Res. 2020,9(12):7440-7449. doi: 10.21037/tcr-20-994
Read this paper
Chang SJ, Liao EC, Yeo HY, et al. Proteomic investigating the cooperative lethal effect of EGFR and MDM2 inhibitors on ovarian carcinoma. Arch Biochem Biophys. 2018,647:10-32. doi: 10.1016/j.abb.2018.04.004
Read this paper
Huang HJ, Lin CC, Chou HC, et al. Proteomic analysis of rhein-induced cyt: ER stress mediates cell death in breast cancer cells. Mol Biosyst. 2014,10(12):3086-100. doi: 10.1039/c4mb00451e
Read this paper